The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Role of omega-3 fatty acids and their metabolites in asthma and allergic diseases
Open accessAbstract
Omega-3 fatty acids, docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), are found naturally in fish oil and are commonly thought to be anti-inflammatory nutrients, with protective effects in inflammatory diseases including asthma and allergies. The mechanisms of these effects remain mostly unknown but are of great interest for their potential therapeutic applications. Large numbers of epidemiological and observational studies investigating the effect of fish intake or omega-3 fatty acid supplementation during pregnancy, lactation, infancy, childhood, and adulthood on asthmatic and allergic outcomes have been conducted. They mostly indicate protective effects and suggest a causal relationship between decreased intake of fish oil in modernized diets and an increasing number of individuals with asthma or other allergic diseases. Specialized pro-resolving mediators (SPM: protectins, resolvins, and maresins) are generated from omega-3 fatty acids such as EPA and DHA via several enzymatic reactions. These mediators counter-regulate airway eosinophilic inflammation and promote the resolution of inflammation in vivo. Several reports have indicated that the biosynthesis of SPM is impaired, especially in severe asthma, which suggests that chronic inflammation in the lung might result from a resolution defect. This article focuses on the beneficial aspects of omega-3 fatty acids and offers recent insights into their bioactive metabolites including resolvins and protectins.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators
Serhan, C. N., Chiang, N., & Van Dyke, T. E. (2008) · Nature Reviews Immunology · doi:10.1038/nri2294 · Cited by 2,932
Resolution of inflammation: the beginning programs the end
Serhan, C. N., & Savill, J. (2005) · Nature Immunology · doi:10.1038/ni1276 · Cited by 2,552
Infection regulates pro-resolving mediators that lower antibiotic requirements
Chiang, N., Fredman, G., Bäckhed, F., Oh, S. F., Vickery, T., Schmidt, B. A., & Serhan, C. N. (2012) · Nature · doi:10.1038/nature11042 · Cited by 664
Resolvin E1 Receptor Activation Signals Phosphorylation and Phagocytosis
Ohira, T., Arita, M., Omori, K., Recchiuti, A., Van Dyke, T. E., & Serhan, C. N. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.044131 · Cited by 278
Self-citationPark, C.-K., Lü, N., Xu, Z.-Z., Liu, T., Serhan, C. N., & Ji, R.-R. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.2443-11.2011 · Cited by 241
Kremmyda, L.-S., Vlachava, M., Noakes, P. S., Diaper, N. D., Miles, E. A., & Calder, P. C. (2011) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-009-8186-2 · Cited by 198
Kitz, R., Rose, M. A., Schubert, R., Beermann, C., Kaufmann, A., Böhles, H. J., Schulze, J., & Zielen, S. (2010) · Respiratory Medicine · doi:10.1016/j.rmed.2010.06.019 · Cited by 44
Research works printed but not linked: 105
- Saravanan, 2010, Cardiovascular effects of marine omega-3 fatty acids, Lancet, 376, 540, 10.1016/S0140-6736(10)60445-X · DOI · Paper page
- Calder, 2013, Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology?, Br J Clin Pharmacol, 75, 645, 10.1111/j.1365-2125.2012.04374.x · DOI · Paper page
- Yates, 2014, Pharmacology and therapeutics of omega-3 polyunsaturated fatty acids in chronic inflammatory disease, Pharmacol Ther, 141, 272, 10.1016/j.pharmthera.2013.10.010 · DOI · Paper page
- Miles, 2014, Omega-6 and omega-3 polyunsaturated fatty acids and allergic diseases in infancy and childhood, Curr Pharm Des, 20, 946, 10.2174/138161282006140220125732 · DOI
- Laidlaw, 2012, Cysteinyl leukotriene receptors, old and new; implications for asthma, Clin Exp Allergy, 42, 1313, 10.1111/j.1365-2222.2012.03982.x · DOI
- Wenzel, 1997, Arachidonic acid metabolites: mediators of inflammation in asthma, Pharmacotherapy, 17, 10.1002/j.1875-9114.1997.tb03696.x · DOI
- Braman, 2006, The global burden of asthma, Chest, 130, 4S, 10.1378/chest.130.1_suppl.4S · DOI · Paper page
- Bell, 2013, Severe asthma: an expanding and mounting clinical challenge, J Allergy Clin Immunol Pract, 1, 110, 10.1016/j.jaip.2013.01.005 · DOI
- Planaguma, 2008, Airway lipoxin A4 generation and lipoxin A4 receptor expression are decreased in severe asthma, Am J Respir Crit Care Med, 178, 574, 10.1164/rccm.200801-061OC · DOI · Paper page
- Bhavsar, 2010, Corticosteroid suppression of lipoxin A4 and leukotriene B4 from alveolar macrophages in severe asthma, Respir Res, 11, 71, 10.1186/1465-9921-11-71 · DOI
- Kazani, 2013, Exhaled breath condensate eicosanoid levels associate with asthma and its severity, J Allergy Clin Immunol, 132, 547, 10.1016/j.jaci.2013.01.058 · DOI
- Fritscher, 2012, Profile of eicosanoids in breath condensate in asthma and COPD, J Breath Res, 6, 026001, 10.1088/1752-7155/6/2/026001 · DOI
- Levy, 2005, Diminished lipoxin biosynthesis in severe asthma, Am J Respir Crit Care Med, 172, 824, 10.1164/rccm.200410-1413OC · DOI · Paper page
- Celik, 2007, Lipoxin A4 levels in asthma: relation with disease severity and aspirin sensitivity, Clin Exp Allergy, 37, 1494, 10.1111/j.1365-2222.2007.02806.x · DOI
- Wu, 2010, Reversed changes of lipoxin A4 and leukotrienes in children with asthma in different severity degree, Pediatr Pulmonol, 45, 333, 10.1002/ppul.21186 · DOI
- Bonnans, 2002, Lipoxins are potential endogenous antiinflammatory mediators in asthma, Am J Respir Crit Care Med, 165, 1531, 10.1164/rccm.200201-053OC · DOI
- Vachier, 2005, Severe asthma is associated with a loss of LX4, an endogenous anti-inflammatory compound, J Allergy Clin Immunol, 115, 55, 10.1016/j.jaci.2004.09.038 · DOI
- Miyata, 2013, Dysregulated synthesis of protectin D1 in eosinophils from patients with severe asthma, J Allergy Clin Immunol, 131, 353, 10.1016/j.jaci.2012.07.048 · DOI
- Freedman, 2004, Association of cystic fibrosis with abnormalities in fatty acid metabolism, N Engl J Med, 350, 560, 10.1056/NEJMoa021218 · DOI · Paper page
- Calvani, 2006, Consumption of fish, butter and margarine during pregnancy and development of allergic sensitizations in the offspring: role of maternal atopy, Pediatr Allergy Immunol, 17, 94, 10.1111/j.1399-3038.2005.00367.x · DOI
- Romieu, 2007, Maternal fish intake during pregnancy and atopy and asthma in infancy, Clin Exp Allergy, 37, 518, 10.1111/j.1365-2222.2007.02685.x · DOI · Paper page
- Salam, 2005, Maternal fish consumption during pregnancy and risk of early childhood asthma, J Asthma, 42, 513, 10.1081/JAS-200067619 · doi:10.1081/jas-200067619
- Sausenthaler, 2007, Maternal diet during pregnancy in relation to eczema and allergic sensitization in the offspring at 2 y of age, Am J Clin Nutr, 85, 530, 10.1093/ajcn/85.2.530 · DOI · Paper page
- Willers, 2007, Maternal food consumption during pregnancy and asthma, respiratory and atopic symptoms in 5-year-old children, Thorax, 62, 773, 10.1136/thx.2006.074187 · DOI · Paper page
- Andreasyan, 2005, A differing pattern of association between dietary fish and allergen-specific subgroups of atopy, Allergy, 60, 671, 10.1111/j.1398-9995.2005.00757.x · DOI
- Antova, 2003, Nutrition and respiratory health in children in six Central and Eastern European countries, Thorax, 58, 231, 10.1136/thorax.58.3.231 · DOI
- Chatzi, 2007, Diet, wheeze, and atopy in school children in Menorca, Spain, Pediatr Allergy Immunol, 18, 480, 10.1111/j.1399-3038.2007.00596.x · DOI
- Dunder, 2001, Diet, serum fatty acids, and atopic diseases in childhood, Allergy, 56, 425, 10.1034/j.1398-9995.2001.056005425.x · DOI
- Hodge, 1996, Consumption of oily fish and childhood asthma risk, Med J Aust, 164, 137, 10.5694/j.1326-5377.1996.tb122010.x · DOI · Paper page
- Huang, 2001, Dietary factors associated with physician-diagnosed asthma and allergic rhinitis in teenagers: analyses of the first Nutrition and Health Survey in Taiwan, Clin Exp Allergy, 31, 259, 10.1046/j.1365-2222.2001.00938.x · DOI
- Kim, 2005, Current asthma and respiratory symptoms among pupils in relation to dietary factors and allergens in the school environment, Indoor Air, 15, 170, 10.1111/j.1600-0668.2005.00334.x · DOI
- Kull, 2006, Fish consumption during the first year of life and development of allergic diseases during childhood, Allergy, 61, 1009, 10.1111/j.1398-9995.2006.01115.x · DOI · Paper page
- Nafstad, 2003, Asthma and allergic rhinitis at 4 years of age in relation to fish consumption in infancy, J Asthma, 40, 343, 10.1081/JAS-120018633 · DOI
- Hoppu, 2005, Breast milk fatty acid composition is associated with development of atopic dermatitis in the infant, J Pediatr Gastroenterol Nutr, 41, 335, 10.1097/01.mpg.0000168992.44428.fa · DOI
- Barros, 2011, Dietary intake of alpha-linolenic acid and low ratio of n-6:n-3 PUFA are associated with decreased exhaled NO and improved asthma control, Br J Nutr, 106, 441, 10.1017/S0007114511000328 · DOI
- Broadfield, 2004, A case-control study of dietary and erythrocyte membrane fatty acids in asthma, Clin Exp Allergy, 34, 1232, 10.1111/j.1365-2222.2004.02032.x · DOI
- Burns, 2007, Low dietary nutrient intakes and respiratory health in adolescents, Chest, 132, 238, 10.1378/chest.07-0038 · DOI
- Kompauer, 2008, Association of fatty acids in serum phospholipids with lung function and bronchial hyperresponsiveness in adults, Eur J Epidemiol, 23, 175, 10.1007/s10654-007-9218-y · DOI
- Li, 2013, Intakes of long-chain omega-3 (n-3) PUFAs and fish in relation to incidence of asthma among American young adults: the CARDIA study, Am J Clin Nutr, 97, 173, 10.3945/ajcn.112.041145 · DOI
- McKeever, 2008, The relation between dietary intake of individual fatty acids, FEV1 and respiratory disease in Dutch adults, Thorax, 63, 208, 10.1136/thx.2007.090399 · DOI
- Woods, 2004, Fatty acid levels and risk of asthma in young adults, Thorax, 59, 105, 10.1136/thorax.2003.009498 · DOI
- Barden, 2004, Fish oil supplementation in pregnancy lowers F2-isoprostanes in neonates at high risk of atopy, Free Radic Res, 38, 233, 10.1080/10715760310001656722 · DOI
- Dunstan, 2007, The effects of fish oil supplementation in pregnancy on breast milk fatty acid composition over the course of lactation: a randomized controlled trial, Pediatr Res, 62, 689, 10.1203/PDR.0b013e318159a93a · DOI
- Dunstan, 2004, Effects of n-3 polyunsaturated fatty acid supplementation in pregnancy on maternal and fetal erythrocyte fatty acid composition, Eur J Clin Nutr, 58, 429, 10.1038/sj.ejcn.1601825 · DOI
- Dunstan, 2004, The effect of supplementation with fish oil during pregnancy on breast milk immunoglobulin A, soluble CD14, cytokine levels and fatty acid composition, Clin Exp Allergy, 34, 1237, 10.1111/j.1365-2222.2004.02028.x · DOI
- Krauss-Etschmann, 2007, Effects of fish-oil and folate supplementation of pregnant women on maternal and fetal plasma concentrations of docosahexaenoic acid and eicosapentaenoic acid: a European randomized multicenter trial, Am J Clin Nutr, 85, 1392, 10.1093/ajcn/85.5.1392 · DOI · Paper page
- Warstedt, 2009, The effects of omega-3 fatty acid supplementation in pregnancy on maternal eicosanoid, cytokine, and chemokine secretion, Pediatr Res, 66, 212, 10.1203/PDR.0b013e3181aabd1c · DOI
- Denburg, 2005, Fish oil supplementation in pregnancy modifies neonatal progenitors at birth in infants at risk of atopy, Pediatr Res, 57, 276, 10.1203/01.PDR.0000148279.72611.1D · DOI
- Dunstan, 2003, Fish oil supplementation in pregnancy modifies neonatal allergen-specific immune responses and clinical outcomes in infants at high risk of atopy: a randomized, controlled trial, J Allergy Clin Immunol, 112, 1178, 10.1016/j.jaci.2003.09.009 · DOI · Paper page
- Dunstan, 2003, Maternal fish oil supplementation in pregnancy reduces interleukin-13 levels in cord blood of infants at high risk of atopy, Clin Exp Allergy, 33, 442, 10.1046/j.1365-2222.2003.01590.x · DOI · Paper page
- Krauss-Etschmann, 2008, Decreased cord blood IL-4, IL-13, and CCR4 and increased TGF-beta levels after fish oil supplementation of pregnant women, J Allergy Clin Immunol, 121, 464, 10.1016/j.jaci.2007.09.018 · DOI · Paper page
- Lauritzen, 2005, Fish oil supplementation of lactating mothers affects cytokine production in 2 1/2-year-old children, Lipids, 40, 669, 10.1007/s11745-005-1429-6 · DOI
- Prescott, 2007, Maternal fish oil supplementation in pregnancy modifies neonatal leukotriene production by cord-blood-derived neutrophils, Clin Sci (Lond), 113, 409, 10.1042/CS20070111 · DOI
- Furuhjelm, 2009, Fish oil supplementation in pregnancy and lactation may decrease the risk of infant allergy, Acta Paediatr, 98, 1461, 10.1111/j.1651-2227.2009.01355.x · DOI · Paper page
- Olsen, 2008, Fish oil intake compared with olive oil intake in late pregnancy and asthma in the offspring: 16 y of registry-based follow-up from a randomized controlled trial, Am J Clin Nutr, 88, 167, 10.1093/ajcn/88.1.167 · DOI · Paper page
- Almqvist, 2007, Omega-3 and omega-6 fatty acid exposure from early life does not affect atopy and asthma at age 5 years, J Allergy Clin Immunol, 119, 1438, 10.1016/j.jaci.2007.01.046 · DOI
- Hodge, 1998, Effect of dietary intake of omega-3 and omega-6 fatty acids on severity of asthma in children, Eur Respir J, 11, 361, 10.1183/09031936.98.11020361 · DOI · Paper page
- Marks, 2006, Prevention of asthma during the first 5 years of life: a randomized controlled trial, J Allergy Clin Immunol, 118, 53, 10.1016/j.jaci.2006.04.004 · DOI · Paper page
- Mihrshahi, 2003, Eighteen-month outcomes of house dust mite avoidance and dietary fatty acid modification in the Childhood Asthma Prevention Study (CAPS), J Allergy Clin Immunol, 111, 162, 10.1067/mai.2003.36 · DOI · Paper page
- Peat, 2004, Three-year outcomes of dietary fatty acid modification and house dust mite reduction in the Childhood Asthma Prevention Study, J Allergy Clin Immunol, 114, 807, 10.1016/j.jaci.2004.06.057 · DOI · Paper page
- Damsgaard, 2007, Fish oil supplementation modulates immune function in healthy infants, J Nutr, 137, 1031
- Vaisman, 2005, The effect of fish oil supplementation on cytokine production in children, Eur Cytokine Netw, 16, 194
- Mihrshahi, 2004, Effect of omega-3 fatty acid concentrations in plasma on symptoms of asthma at 18 months of age, Pediatr Allergy Immunol, 15, 517, 10.1111/j.1399-3038.2004.00187.x · DOI
- Nagakura, 2000, Dietary supplementation with fish oil rich in omega-3 polyunsaturated fatty acids in children with bronchial asthma, Eur Respir J, 16, 861, 10.1183/09031936.00.16586100 · DOI · Paper page
- Emelyanov, 2002, Treatment of asthma with lipid extract of New Zealand green-lipped mussel: a randomised clinical trial, Eur Respir J, 20, 596, 10.1183/09031936.02.02632001 · DOI
- Mickleborough, 2006, Protective effect of fish oil supplementation on exercise-induced bronchoconstriction in asthma, Chest, 129, 39, 10.1378/chest.129.1.39 · DOI · Paper page
- Mickleborough, 2003, Fish oil supplementation reduces severity of exercise-induced bronchoconstriction in elite athletes, Am J Respir Crit Care Med, 168, 1181, 10.1164/rccm.200303-373OC · DOI · Paper page
- Schubert, 2009, Effect of n-3 polyunsaturated fatty acids in asthma after low-dose allergen challenge, Int Arch Allergy Immunol, 148, 321, 10.1159/000170386 · DOI
- Bilal, 2011, Fat-1 transgenic mice with elevated omega-3 fatty acids are protected from allergic airway responses, Biochim Biophys Acta, 1812, 1164, 10.1016/j.bbadis.2011.05.002 · DOI
- Morin, 2011, Docosahexaenoic acid derivative prevents inflammation and hyperreactivity in lung: implication of PKC-potentiated inhibitory protein for heterotrimeric myosin light chain phosphatase of 17 kD in asthma, Am J Respir Cell Mol Biol, 45, 366, 10.1165/rcmb.2010-0156OC · DOI
- Morin, 2013, MAG-EPA resolves lung inflammation in an allergic model of asthma, Clin Exp Allergy, 43, 1071, 10.1111/cea.12162 · DOI
- Yokoyama, 2000, Effect of aerosolized docosahexaenoic acid in a mouse model of atopic asthma, Int Arch Allergy Immunol, 123, 327, 10.1159/000053645 · DOI
- Schuster, 2014, Dietary long-chain omega-3 fatty acids do not diminish eosinophilic pulmonary inflammation in mice, Am J Respir Cell Mol Biol, 50, 626, 10.1165/rcmb.2013-0136OC · DOI
- Yin, 2009, Dietary supplementation of omega-3 fatty acid-containing fish oil suppresses F2-isoprostanes but enhances inflammatory cytokine response in a mouse model of ovalbumin-induced allergic lung inflammation, Free Radic Biol Med, 47, 622, 10.1016/j.freeradbiomed.2009.05.033 · DOI
- Buckley, 2014, Proresolving lipid mediators and mechanisms in the resolution of acute inflammation, Immunity, 40, 315, 10.1016/j.immuni.2014.02.009 · DOI · Paper page
- Yamada, 2011, Eosinophils promote resolution of acute peritonitis by producing proresolving mediators in mice, FASEB J, 25, 561, 10.1096/fj.10-170027 · DOI
- Isobe, 2013, Stereochemical assignment and anti-inflammatory properties of the omega-3 lipid mediator resolvin E3, J Biochem, 153, 355, 10.1093/jb/mvs151 · DOI
- Isobe, 2012, Identification and structure determination of novel anti-inflammatory mediator resolvin E3, 17,18-dihydroxyeicosapentaenoic acid, J Biol Chem, 287, 10525, 10.1074/jbc.M112.340612 · DOI · Paper page
- Kubota, 2014, Eicosapentaenoic acid is converted via omega-3 epoxygenation to the anti-inflammatory metabolite 12-hydroxy-17,18-epoxyeicosatetraenoic acid, FASEB J, 28, 586, 10.1096/fj.13-236224 · DOI
- Chiang, 2006, The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo, Pharmacol Rev, 58, 463, 10.1124/pr.58.3.4 · DOI · Paper page
- Marcheselli, 2010, Neuroprotectin D1/protectin D1 stereoselective and specific binding with human retinal pigment epithelial cells and neutrophils, Prostagl Leukot Essent Fat Acids, 82, 27, 10.1016/j.plefa.2009.10.010 · DOI
- Krishnamoorthy, 2010, Resolvin D1 binds human phagocytes with evidence for proresolving receptors, Proc Natl Acad Sci U S A, 107, 1660, 10.1073/pnas.0907342107 · DOI · Paper page
- Dalli, 2013, Resolvin D3 and aspirin-triggered resolvin D3 are potent immunoresolvents, Chem Biol, 20, 188, 10.1016/j.chembiol.2012.11.010 · DOI · Paper page
- Arita, 2005, Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1, J Exp Med, 201, 713, 10.1084/jem.20042031 · DOI · Paper page
- Arita, 2007, Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation, J Immunol, 178, 3912, 10.4049/jimmunol.178.6.3912 · DOI · Paper page
- Schwab, 2007, Resolvin E1 and protectin D1 activate inflammation-resolution programmes, Nature, 447, 869, 10.1038/nature05877 · DOI · Paper page
- Levy, 2007, Protectin D1 is generated in asthma and dampens airway inflammation and hyperresponsiveness, J Immunol, 178, 496, 10.4049/jimmunol.178.1.496 · DOI · Paper page
- Camateros, 2007, Chronic asthma-induced airway remodeling is prevented by toll-like receptor-7/8 ligand S28463, Am J Respir Crit Care Med, 175, 1241, 10.1164/rccm.200701-054OC · DOI
- Grela, 2011, The TLR7 agonist R848 alleviates allergic inflammation by targeting invariant NKT cells to produce IFN-gamma, J Immunol, 186, 284, 10.4049/jimmunol.1001348 · DOI
- Xirakia, 2010, Toll-like receptor 7-triggered immune response in the lung mediates acute and long-lasting suppression of experimental asthma, Am J Respir Crit Care Med, 181, 1207, 10.1164/rccm.200908-1255OC · DOI
- Koltsida, 2013, Toll-like receptor 7 stimulates production of specialized pro-resolving lipid mediators and promotes resolution of airway inflammation, EMBO Mol Med, 5, 762, 10.1002/emmm.201201891 · DOI
- Levy, 2012, Resolvin D1 and resolvin E1 promote the resolution of allergic airway inflammation via shared and distinct olecular counter-regulatory pathways, Front Immunol, 3, 390, 10.3389/fimmu.2012.00390 · DOI
- Rogerio, 2012, Resolvin D1 and aspirin-triggered resolvin D1 promote resolution of allergic airways responses, J Immunol, 189, 1983, 10.4049/jimmunol.1101665 · DOI · Paper page
- Aoki, 2008, Resolvin E1 dampens airway inflammation and hyperresponsiveness in a murine model of asthma, Biochem Biophys Res Commun, 367, 509, 10.1016/j.bbrc.2008.01.012 · DOI · Paper page
- Aoki, 2010, Protective effect of resolvin E1 on the development of asthmatic airway inflammation, Biochem Biophys Res Commun, 400, 128, 10.1016/j.bbrc.2010.08.025 · DOI
- Haworth, 2011, NK cells are effectors for resolvin E1 in the timely resolution of allergic airway inflammation, J Immunol, 186, 6129, 10.4049/jimmunol.1004007 · DOI
- Haworth, 2008, Resolvin E1 regulates interleukin 23, interferon-gamma and lipoxin A4 to promote the resolution of allergic airway inflammation, Nat Immunol, 9, 873, 10.1038/ni.1627 · DOI · Paper page
- Barnig, 2013, Lipoxin A4 regulates natural killer cell and type 2 innate lymphoid cell activation in asthma, Sci Transl Med, 5, 174ra26, 10.1126/scitranslmed.3004812 · DOI · Paper page
- Doyle, 2014, Development of a membrane-anchored chemerin receptor agonist as a novel modulator of allergic airway inflammation and neuropathic pain, J Biol Chem, 289, 13385, 10.1074/jbc.M113.522680 · DOI
- Levy, 2002, Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A(4), Nat Med, 8, 1018, 10.1038/nm748 · DOI · Paper page
- Levy, 2007, Lipoxin A4 stable analogs reduce allergic airway responses via mechanisms distinct from CysLT1 receptor antagonism, FASEB J, 21, 3877, 10.1096/fj.07-8653com · DOI
- Sanak, 2000, Aspirin-tolerant asthmatics generate more lipoxins than aspirin-intolerant asthmatics, Eur Respir J, 16, 44, 10.1034/j.1399-3003.2000.16a08.x · DOI · Paper page
- Yamaguchi, 2011, Urinary concentrations of 15-epimer of lipoxin A(4) are lower in patients with aspirin-intolerant compared with aspirin-tolerant asthma, Clin Exp Allergy, 41, 1711, 10.1111/j.1365-2222.2011.03839.x · DOI
- Hasan, 2012, Lipoxin A(4) and 8-isoprostane in the exhaled breath condensate of children hospitalized for status asthmaticus, Pediatr Crit Care Med, 13, 141, 10.1097/PCC.0b013e3182231644 · DOI
- Tahan, 2008, The role of lipoxin A4 in exercise-induced bronchoconstriction in asthma, J Asthma, 45, 161, 10.1080/02770900701847068 · DOI
Cited by
Effectiveness of probiotics, prebiotics, and prebiotic‐like components in common functional foods
Peng, M., Tabashsum, Z., Anderson, M., Truong, A., Houser, A. K., Padilla, J., Akmel, A., Bhatti, J., Rahaman, S. O., & Biswas, D. (2020) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12565 · Cited by 258
Thompson, M., Hein, N., Hanson, C., Smith, L. M., Anderson-Berry, A., Richter, C. K., Stessy Bisselou, K., Kusi Appiah, A., Kris-Etherton, P., Skulas-Ray, A. C., et al. (2019) · Nutrients · doi:10.3390/nu11010177 · Cited by 98
Fernandes, T., & Cordeiro, N. (2021) · Marine Drugs · doi:10.3390/md19100573 · Cited by 95
“The ω3-pathway is initiated with the ∆6 desaturation of LA and leads to the synthesis of ω3-LC-PUFA eicosapentaenoic acid (EPA, C20:5ω3) and DHA, whereas theω6-pathway initiates with the ∆6 desaturation of ALA and produces the ω6-LC-PUFA, AA [58].”
BackgroundInfluentialIs There Something Fishy About Fish Oil?
Šunderić, M., Robajac, D., Gligorijević, N., Miljuš, G., Nedić, O., Smilkov, K., Ackova, D. G., Rudić-Grujić, V., & Penezić, A. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190705185800 · Cited by 5
Metadata
- Authors
- Miyata, J., & Arita, M.
- Venue
- Allergology International
- Publisher
- Elsevier BV
- Published
- 2015-01
- Volume
- 64
- Issue
- 1
- Pages
- 27-34
- ISSN
- 1323-8930 (ISSN-L)
- OpenAlex
- W2110465069
- Cited by
- 235
- References
- 7
- FWCI
- 8.39
- Type
- journal article
- Language
- en
- Open access
- gold
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor, 118 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Role of omega-3 fatty acids and their metabolites in asthma and allergic diseases. https://app.cochat.ai/papers/10.1016/j.alit.2014.08.003
- The paper
- Miyata, J., & Arita, M. (2015). Role of omega-3 fatty acids and their metabolites in asthma and allergic diseases. Allergology International. https://doi.org/10.1016/j.alit.2014.08.003
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.